GTB-3550
GT Biopharma
[]
$gtbp gt biopharma presents preclinical data demonstrating second-generation cd19 targeting tri-specific killer engager (trike ) driving robust nk cell function against b cell malignancies at eha 2022 congress 
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft